Lilly adds to genetic meds push with Genetic Leap alliance
In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted t
Beyond clinical: Boosting recruitment and retention with SDO...
The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.
The biosimilars dance: How drugmakers game the US patent sys...
When the primary patent on a blockbuster drug expires, affordable generic or biosimilar competition is expected to balance the market, offering relief to patients who could not afford the h
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
The Life Sciences Generative AI Council and a sustainable te...
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
PM Society’s sixth Careers Event – 26th February 2025
For the sixth year running the PM Society will be bringing their ‘A Career in Pharmaceutical and Healthcare Communications’ event back to the Royal Society of Medicine.
Complex Bioengineering for Cell Therapies Summit
Unravel Complex TME Biology, Optimize Payload Delivery, & Overcome Early Risks in Developing Advanced Logic Gated & Dual-Targeted Cell Therapies
